5-HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

British Journal of Pharmacology

Volumn 167, Issue 2, 2012, Pages 436-449

  Woods, S ^a   Clarke, N N ^a   Layfield, R ^a   Fone, K C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

5 HT6receptor; conditioned emotional response; E 6801; EMD 386088; fear motivated learning; SB 271046

Indexed keywords

5 CHLORO 2 METHYL 3 (1,2,3,6 TETRAHYDROPYRIDIN 4 YL) 1H INDOLE; 5 CHLORO N (4 METHOXY 3 PIPERAZIN 1 YLPHENYL) 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 6 CHLORO N [3 [2 (DIMETHYLAMINO)ETHYL] 1H INDOL 5 YL]IMIDAZO[2,1 B]THIAZOLE 5 SULFONAMIDE; E 6801; EMD 386088; SB 270146; SEROTONIN 6 ANTAGONIST; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; EMOTION; FOOTSHOCK; GLUTAMATERGIC SYSTEM; HUMAN; HUMAN CELL; LEARNING DISORDER; MALE; MEMORY DISORDER; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; STATE DEPENDENT LEARNING;

ANIMALS; CONDITIONING (PSYCHOLOGY); DIZOCILPINE MALEATE; ELECTRIC STIMULATION; EMOTIONS; INDOLES; LEARNING; MALE; PYRIDINES; RATS; RECEPTORS, SEROTONIN; SCOPOLAMINE HYDROBROMIDE; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SULFONAMIDES; THIAZOLES; THIOPHENES;

EID: 84865425244     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02022.x     Document Type: Article

References (87)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164: S1-S324.
2. Anagnostaras SG, Maren S, Sage JR, Goodrich S, Fanselow MS, (1999). Scopolamine and pavlovian fear conditioning in rats: dose-effect analysis. Neuropsychopharmacology 21: 731-744.
3. Belleville S, Sylvain-Roy S, de Boysson C, Menard MC, (2008). Characterizing the memory changes in persons with mild cognitive impairment. In:, Sossin WS, Lacaille JC, Castellucci VF, Belleville S, (eds). Essence of Memory., Vol. 169. Elsevier Science Bv: Amsterdam, pp. 365-375. (Pubitemid 351451914)
4. Bos M, Sleight AJ, Godel T, Martin JR, Riemer C, Stadler H, (2001). 5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides. Eur J Med Chem 36: 165-178. (Pubitemid 32304518)
5. Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, et al,. (1999). 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2- benzothiophenesulfonamide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 42: 202-205. (Pubitemid 29069853)
6. de Bruin NMWJ, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, et al,. (2011). Two novel 5-HT(6) receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 96: 392-402.
7. Burnham KE, Baxter MG, Bainton JR, Southam E, Dawson LA, Bannerman DM, et al,. (2010). Activation of 5-HT6 receptors facilitates attentional set shifting. Psychopharmacology 208: 13-21.
8. Codony X, Miguel Vela J, Javier Ramirez M, (2011). 5-HT(6) receptor and cognition. Curr Opin Pharmacol 11: 94-100.
9. Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong HX, (2005). Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology 30: 2135-2143. (Pubitemid 41643964)
10. Dawson LA, Nguyen HQ, Li P, (2000). In vivo effects of the 5-HT6 antagonist SE-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130: 23-26. (Pubitemid 30248421)
11. Dawson LA, Nguyen HQ, Li P, (2001). The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25: 662-668. (Pubitemid 32995948)
12. De Foubert G, O'Neill MJ, Zetterstrom TSC, (2007). Acute onset by 5-HT6-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 147: 778-785. (Pubitemid 46990655)
13. Fanselow MS, (2000). Contextual fear, gestalt memories, and the hippocampus. Behav Brain Res 110: 73-81. (Pubitemid 30236293)
14. Finn DP, Forte KCF, Beckett SRG, Baxter JA, Ansell L, Marsden CA, et al,. (2007). The effects of pharmacological blockade of the 5-HT6 receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. Eur J Pharmacol 569: 59-63. (Pubitemid 47175884)
15. Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Merce R, et al,. (2006). Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br J Pharmacol 148: 973-983. (Pubitemid 44543615)
16. Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, et al,. (2004). The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29: 93-100. (Pubitemid 38068018)
17. Fone KCF, (2008). An update on the role of the 5-hydroxytryptamine(6) receptor in cognitive function. Neuropharmacology 55: 1015-1022.
18. Gale GD, Anagnostaras SG, Godsil BP, Mitchell S, Nozawa T, Sage JR, et al,. (2004). Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. J Neurosci 24: 3810-3815. (Pubitemid 38509411)
19. Gravius A, Laszy J, Pietraszek M, Saghy K, Nagel J, Chambon C, et al,. (2011). Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity. Behav Pharmacol 22: 122-135.
20. Hatcher PD, Brown VJ, Tait DS, Bate S, Overend P, Hagan JJ, et al,. (2005). 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology 181: 253-259. (Pubitemid 41492195)
21. Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H, (2008). Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol Ther 117: 207-231.
22. Herbener ES, (2009). Impairment in long-term retention of preference conditioning in schizophrenia. Biol Psychiatry 65: 1086-1090.
23. Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, et al,. (2006). SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553: 109-119. (Pubitemid 44779592)
24. Hoefer M, Allison SC, Schauer GF, Neuhaus JM, Hall J, Dang JN, et al,. (2008). Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease. Brain 131: 1646-1657. (Pubitemid 351806464)
25. Jones CA, Brown AM, Auer DP, Fone KCF, (2011). The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology 214: 269-283.
26. Kendall I, Slotten HA, Codony X, Burgueno J, Pauwels PJ, Vela JM, et al,. (2011). E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology 213: 413-430.
27. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010) NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
28. Kim JJ, Decola JP, Landeirafernandez J, Fanselow MS, (1991). N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not experession of fear conditioning. Behav Neurosci 105: 126-133.
29. King M, Spicer C, Sleight A, Marsden C, Fone K, (2009). Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task. Psychopharmacology 202: 111-123.
30. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KCF, (2004). 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47: 195-204. (Pubitemid 38824643)
31. King MV, Marsden CA, Fone KCF, (2008). A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29: 482-492.
32. Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, et al,. (1996). Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 66: 47-56. (Pubitemid 26010763)
33. Kohen R, Fashingbauer LA, Heidmann DEA, Guthrie CR, Hamblin MW, (2001). Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Mol Brain Res 90: 110-117. (Pubitemid 32537632)
34. Landeira-Fernandez J, Kim JJ, DeCola JP, Fanselow MS, (2006). Immediate shock deficit in fear conditioning: effects of shock manipulations. Behav Neurosci 120: 873-879.
35. Lieben CKJ, Blokland A, Sik A, Sung E, van Nieuwenhuizen P, Schreiber R, (2005). The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30: 2169-2179. (Pubitemid 41643968)
36. Liem-Moolenaar M, Rad M, Zamuner S, Cohen AF, Lemme F, Franson KL, et al,. (2011). Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT(6) antagonist SB742457 (repeated doses) in healthy men. Br J Clin Pharmacol 71: 907-916.
37. Lindner MD, Hodges DB, Hogan JB, Orie AF, Corsa JA, Barten DM, et al,. (2003). An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 307: 682-691. (Pubitemid 37310684)
38. Loiseau F, Dekeyne A, Millan MJ, (2008). Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology 196: 93-104.
39. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
40. McHugh TJ, Tonegawa S, (2007). Spatial exploration is required for the formation of contextual fear memory. Behav Neurosci 121: 335-339. (Pubitemid 47445084)
41. Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, et al,. (2010). Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in alzheimer's disease. Curr Alzheimer Res 7: 374-385.
42. Maher-Edwards G, Dixon R, Hunter J, Gold M, Hopton G, Jacobs G, et al,. (2011). SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. Int J Geriatr Psychiatry 26: 536-544.
43. Marcos B, Gil-Bea FJ, Hirst WD, Garcia-Alloza M, Ramirez MJ, (2006). Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24: 1299-1306. (Pubitemid 44401652)
44. Marcos B, Chuang TT, Gil-Bea FJ, Ramirez MJ, (2008). Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Br J Pharmacol 155: 434-440.
45. Maren S, Fanselow MS, (1997). Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats. Neurobiol Learn Mem 67: 142-149. (Pubitemid 27424468)
46. Marsden CA, King MV, Fone KCF, (2011). Influence of social isolation in the rat on serotonergic function and memory-relevance to models of schizophrenia and the role of 5-HT(6) receptors. Neuropharmacology 61: 400-407.
47. Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, et al,. (2005). 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorg Med Chem Lett 15: 4230-4234. (Pubitemid 41187992)
48. Meffre J, Seveno M, Milian MJ, La Cour CM, Dekeyne A, Bockaert J, et al,. (2010). Proteomic and functional analysis suggests that 5-HT6 receptors compromise cognition by recruiting mTOR. Schizophr Res 117: 373-374.
49. Meneses A, (2001a). Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation. Behav Brain Res 118: 107-110. (Pubitemid 32037119)
50. Meneses A, (2001b). Role of 5-HT6 receptors in memory formation. Drug News Perspect 14: 396-400. (Pubitemid 33140705)
51. Meneses A, Perez-Garcia G, Liy-Salmeron G, Flores-Galvez D, Castillo C, Castillo E, (2008). The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation. Behav Brain Res 195: 112-119.
52. Mitchell ES, Neumaier JF, (2005). 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108: 320-333. (Pubitemid 41691871)
53. Mitchell ES, Hoplight BJ, Lear SP, Neumaier JF, (2006). BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism. Neuropharmacology 50: 412-420. (Pubitemid 43209037)
54. Mitchell ES, Sexton T, Neumaier JF, (2007). Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning. Neuropsychopharmacology 32: 1520-1530. (Pubitemid 46920161)
55. Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR, (1993). Cloning and expression of a novel serotonin receptor with high-affinity for tricyclic psychotropic-drugs. Mol Pharmacol 43: 320-327. (Pubitemid 23081986)
56. Myskiw JC, Rossato JI, Bevilaqua LRM, Medina JH, Izquierdo I, Cammarota M, (2008). On the participation of mTOR in recognition memory. Neurobiol Learn Mem 89: 338-351. (Pubitemid 351318273)
57. Nikiforuk A, Kos T, Wesolowska A, (2011). The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology 217: 411-418.
58. Nilsson M, Hansson S, Carlsson A, Carlsson ML, (2007). Differential effects of the N-methyl-D-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice. Neuroscience 149: 123-130. (Pubitemid 47488657)
59. Riccioni T, Bordi F, Minetti P, Spadoni G, Yun HM, Im BH, et al,. (2011). ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT(6) receptors. Eur J Pharmacol 661: 8-14.
60. Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RHP, et al,. (2003). Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6- pyrrolidin-1- ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46: 1273-1276. (Pubitemid 36428233)
61. Rogers DC, Hagan JJ, (2001). 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158: 114-119. (Pubitemid 33020829)
62. Romero G, Sanchez E, Pujol M, Perez P, Codony X, Holenz J, et al,. (2006). Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways. Br J Pharmacol 148: 1133-1143. (Pubitemid 44223019)
63. Routledge C, Bromidge SM, Moss SF, Price GW, Hirst W, Newman H, et al,. (2000). Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist. Br J Pharmacol 130: 1606-1612. (Pubitemid 30611938)
64. Ruat M, Traiffort E, Arrang JM, Tardivellacombe J, Diaz J, Leurs R, et al,. (1993). A novel rat serotonin (5-HT6) receptor-molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193: 268-276. (Pubitemid 23199942)
65. Rushe TM, Woodruff PWR, Murray RM, Morris RG, (1999). Episodic memory and learning in patients with chronic schizophrenia. Schizophr Res 35: 85-96. (Pubitemid 29023557)
66. Russell MGN, Dias R, (2002). Memories are made of this (perhaps): a review of serotonin 5-HT6 receptor ligands and their biological functions. Curr Top Med Chem 2: 643-654.
67. Schaffhauser H, Mathiasen JR, DiCamillo A, Huffman MJ, Lu LD, McKenna BA, et al,. (2009). Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 78: 1035-1042.
68. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, et al,. (2008a). Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33: 1323-1335. (Pubitemid 351521711)
69. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, et al,. (2008b). Neuropharmacological profile of novel and selective 5-HT(6) receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33: 1323-1335. (Pubitemid 351521711)
70. Schreiber R, Sleight AJ, Woolley ML, (2006). 5-HT6 receptors as targets for the treatment of cognitive deficits in schizophrenia. Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics, 495-515.
71. Schreiber R, Vivian J, Hedley L, Szczepanski K, Secchi RL, Zuzow M, et al,. (2007). Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. Eur Neuropsychopharmacol 17: 277-288. (Pubitemid 46135932)
72. Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR, (1993). Molecular-cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268: 18200-18204. (Pubitemid 23260343)
73. Sigurdsson T, Doyere V, Cain CK, LeDoux JE, (2007). Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 52: 215-227. (Pubitemid 46026826)
74. Stiedl O, Birkenfeld K, Palve M, Spiess J, (2000). Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav Brain Res 116: 157-168.
75. Svenningsson P, Tzavara ET, Qi HS, Carruthers R, Witkin JM, Nomikos GG, et al,. (2007). Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27: 4201-4209. (Pubitemid 46597167)
76. Tassone A, Madeo G, Schirinzi T, Vita D, Puglisi F, Ponterio G, et al,. (2011). Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. Neuropharmacology 61: 632-637.
77. Tronson NC, Schrick C, Fischer A, Sananbenesi F, Pages G, Pouyssegur J, et al,. (2008). Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology 33: 1570-1583. (Pubitemid 351684712)
78. Upton N, Chuang TT, Hunter AJ, Virley DJ, (2008). 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurother 5: 458-469. (Pubitemid 351952494)
79. Wallenstein GV, Vago DR, (2001). Intrahippocampal scopolamine impairs both acquisition and consolidation of contextual fear conditioning. Neurobiol Learn Mem 75: 245-252. (Pubitemid 34131120)
80. Wesolowska A, Nikiforuk A, (2007). Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52: 1274-1283. (Pubitemid 46527703)
81. Wesolowska A, Nikiforuk A, Stachowicz K, (2007). Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol 18: 439-446. (Pubitemid 47356370)
82. West PJ, Marcy VR, Marino MJ, Schaffhauser H, (2009). Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in the rat hippocampus. Neuroscience 164: 692-701.
83. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KCF, (2001). A role for 5-ht(6) receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41: 210-219. (Pubitemid 32728092)
84. Woolley ML, Marsden CA, Fone KCF, (2004). 5-ht6 receptors. Curr Drug Targets CNS Neurol Disord 3: 59-79.
85. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA, (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122: 150-202.
86. Yun HM, Kim S, Kim HJ, Kostenis E, Kim JI, Seong JY, et al,. (2007). The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J Biol Chem 282: 5496-5505. (Pubitemid 47093777)
87. Yun HM, Baik JH, Kang I, Jin C, Rhim H, (2010). Physical Interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival. J Biol Chem 285: 10016-10029.